ArticleScientific reports2017

Publisher Correction: PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation.

Chao Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.